Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Nucl Med Biol. 2013 Feb 28;40(4):524–528. doi: 10.1016/j.nucmedbio.2013.01.008

Table 2.

FDG biodistribution data in mice with PC3 xenografts

Organ Avg. %ID/g±SD
Tumor/Organ
Control (n=5) Acipimox (n=5) P Control Acipimox
Tumor 3.59±1.35 7.21±1.93 0.02* 1.00 1.00
Blood 1.44±0.28 1.23±0.54 0.64 2.49 5.86
Heart 56.94±23.80 41.21±23.47 0.66 0.06 0.17
Lungs 6.42±2.73 6.69±1.07 0.68 0.56 1.08
Liver 1.43±0.42 2.06±0.69 0.16 2.51 3.50
Spleen 5.23±0.92 7.47±1.23 0.01* 0.69 0.97
Kidney 13.28±1.57 24.40±9.72 0.06 0.27 0.30
Muscle 2.21±0.72 2.34±1.32 0.55 1.62 3.08
Bone 2.56±1.10 3.54±1.40 0.30 1.40 2.04
Brain 7.07±1.15 9.55±3.17 0.19 0.51 0.75

Abbreviations: %ID/g: percentage of injected dose per gram; SD: standard deviation;

significant differences (P<0.05) marked with *.